About US
Contact us
-
Little-known Chinese firm builds $79M COVID-19 vaccine plant, eyes production next yearNo animal data, no wordon the timeline for a clinical trial, yet one little-known Chinese company is already building a multimillion-dollar facility for a COVID-19 vaccine candidate. On Saturday, Chi2020/7/16
-
Moderna has started turning out COVID-19 vaccine doses for quick shipment if approved: CEOModerna and its partners in the federal government are just now gearing up for a late-stage COVID-19 vaccine trial set to launch later this month, but at the same time, the mRNA biotech is prepping a2020/7/16
-
Gilead's remdesivir rescued from 'scrapheap' by taxpayers, who deserve a better price: lawmakerGilead Science’s remdesivir is on the very short list of drugs that have posted positive data in COVID-19, but now one U.S. lawmaker argues the company priced the medicine too high. Taxpayers spent n2020/7/15
-
Merck KGaA's manufacturing group could see billions from COVID-19 work: analystCOVID-19 vaccines are moving forward at record speeds, but market watchers have cautioned about the looming manufacturing challenges.Merck KGaA, with its manufacturing services outfit,could see billi2020/7/15
-
J&J's Tremfya grabs psoriatic arthritis nod, setting up a battle with Cosentyx, Taltz and moreJohnson & Johnson is battling giants in the immunology field with itsIL-23 inhibitorTremfya. With other next-gen drugs already crowding the market, J&J now has the FDA's nod to take Tremfya i2020/7/14
-
Warp Speed initiative aims for COVID-19 vaccine production within 6 weeks: ReutersThe U.S. governmenthas dumped billionsinto COVID-19 vaccine developmentand manufacturing as part of its Warp Speed initiative. Now, withvaccine makers moving rapidlytoward approval, the administratio2020/7/14
-
Amgen doubles down on BeiGene investment as Chinese biotech aims to raise $2.1BIn an eye-catching transpacific collaboration last year, Amgen poured out $2.7 billion to tap into BeiGene’s commercial and R&D expertise in China. But what if an additional equity raise diluted2020/7/13
-
Roche's Tecentriq-Avastin pairing fails to keep ovarian cancer at bayImmune checkpoint inhibitors have gained a foothold in several tumor types, but not so much in ovarian cancer. Now, an early attempt by Roche to change that situation has failed. Adding PD-L1 inhibit2020/7/13
-
Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions' of COVID-19 shot dosesModerna is on a steady marchto market with its mRNA-based COVID-19 vaccine, and the company is snapping up manufacturing capacity along the way. After inking onefill-finish deal with major CDMO Catal2020/7/10
-
FDA blasts India's Vega Life Sciences over deleted data from faulty solvent testingThe laundry list of potential faults during an FDA inspection runs long, but brazen errorstend to get investigators especially riled up. That was certainly the case with Indian drugmaker Vega Life Sc2020/7/10